3D neuroimaging; Endogenous neurotransmitter release measure; Functional neuroimaging; PET-computed tomography, PET-CT; PET-magnetic resonance, PET-MR; Positron emission tomography, PET; Protein density measurement; Synaptic dopamine release evaluation
Positron emission tomography (PET) is a functional imaging technique that allows the exploration of brain and body metabolic processes. The technique is based on the administration of a biologically active molecule labeled with a radioactive isotope (tracer). The signal produced by the tracer agent is detected by a gamma camera and reconstructed to generate a 3D image. In order to improve anatomical localization, PET imaging is usually associated to the acquisition, during the same session, of a morphological scan (positron emission tomography-computed tomography (PET-CT), or, more recently, positron emission tomography-magnetic resonance (PET-MR) (Aiello et al. 2016).
References and Readings
- Nimura, T., Yamaguchi, K., Ando, T., Shibuya, S., Oikawa, T., Nakagawa, A., …, & Tominaga, T. (2005). Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: A positron emission tomography study. Journal of Neurosurgery, 103(6), 968–973. https://doi.org/10.3171/jns.2005.103.6.0968.CrossRefGoogle Scholar
- Shimojo, M., Higuchi, M., Suhara, T., & Sahara, N. (2015). Imaging multimodalities for dissecting Alzheimer’s disease: Advanced technologies of positron emission tomography and fluorescence imaging. Frontiers in Neuroscience, 9, 482. https://doi.org/10.3389/fnins.2015.00482.CrossRefPubMedCentralPubMedGoogle Scholar